Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock?
Acadia Healthcare Company is a leading pure-play behavioral healthcare provider with 279 facilities and a growing patient base. ACHC's revenue continues to climb, but profitability is pressured by rising labor costs and a tight labor market. Despite higher net leverage and volatile cash flows, shares appear attractively priced on an absolute basis.
ACHC's premium valuation faces a key test as facility growth and stronger EBITDA guidance compete with rising costs and weaker returns.
Acadia Healthcare NASDAQ: ACHC reported second-quarter 2026 results that management said were in line with expectations, supported by progress at recently opened facilities, disciplined spending and strong free cash flow generation.
ACHC beats Q2 earnings and revenue estimates as admissions rise and residential treatment grow, prompting higher 2026 guidance despite profit pressure.
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.83 per share a year ago.
The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand rises and earnings outlook improves. THC, UHS, ACHC and CYH stand out.
ACHC is shifting from expansion to returns, raising EBITDA guidance as mature facilities and rising demand support its turnaround strategy.
ACHC shares surge 82% YTD while it expands bed capacity, boosts cash flow and rides on rising behavioral health demand.
ACHC Q1 tops estimates with 37 cents EPS and 7.6% revenue growth, driven by higher patient days and admissions despite shorter stays and rising costs.
Acadia Healthcare Company, Inc. (ACHC) Q1 2026 Earnings Call Transcript
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.4 per share a year ago.